© 2002 by Oxford University Press
Journal of the National Cancer Institute, Vol. 94, No. 20, 1526,
October 16, 2002
© 2002 Oxford University Press
NEWS |
Awards, Appointments, Announcements
Louis M. Weiner, M.D., was appointed vice president for translational research at Fox Chase Cancer Center in Philadelphia.Weiner will also continue to serve as chairman of the department of medical oncology.
Phillips Named
Gordon L. Phillips II, M.D., has been named director of the Blood and Marrow Transplant and Leukemia Program at the James P. Wilmot Cancer Center at the University of Rochester Medical Center.
Phillips was previously director of the blood and marrow transplant program at the University of Maryland’s Greenebaum Cancer Center and before that at the University of Kentucky. He has also served as director of the leukemia and bone marrow transplant program of British Columbia.
New Faculty at Roswell Park
Roswell Park Cancer Institute, Buffalo, New York, has appointed two physicians and three researchers to faculty positions.
Petr Starostik, M.D., was appointed chief of molecular diagnostics in the Department of Pathology and Laboratory Medicine. He was previously at Wuerzburg University in Germany where he served as director of the Molecular Diagnostics Laboratory.
Gary Y. Yang, M.D., was appointed attending physician in the Department of Radiation Medicine. He was previously at Johns Hopkins University in Baltimore.
Three researchers will be joining RPCI’s Department of Pharmacology and Therapeutics: Gokul M. Das, Ph.D., previously of the University of Texas Health Science Center at San Antonio; Barbara A. Foster, Ph.D., from the University of Pittsburgh; and Michael T. Moser, Ph.D., from Loyola University Medical Center, Cardinal Bernadin Cancer Center in Maywood, Ill.
Guttmacher Named
Alan E. Guttmacher, M.D., has been named second deputy director of the National Human Genome Research Institute. He will oversee the translation of the findings of the Human Genome Project into new diagnostic tests and therapies.
Guttmacher is also the acting director of the NHGRI Office of Policy, Planning and Communications.
Gershenson Named
David M. Gershenson, M.D., has been named director of the Division of Gynecologic Oncology at the University of Texas M. D. Anderson Cancer Center in Houston. He was previously professor and chairman of the Department of Gynecologic Oncology.
Geneticist Recognized
Albert de la Chapelle, M.D., Ph.D., director of the Human Cancer Genetics Program at the Ohio State University Comprehensive Cancer Center, has won the 2002 Mauro Baschirotto Award for outstanding achievement in the field of human genetics.
de la Chapelle discovered that various genetic mutations present in acute myeloid leukemia predicted a poorer prognosis. He also discovered that the vast majority of hereditary nonpolyposis colorectal cancer families have mutations in only a handful of genes, and that mismatch repair of these genes is a key pathogenic pathways in cancer development.
CiteULike 
Connotea 
Del.icio.us What's this?
| ||||||||||||||||||||||||||||||||||||||||||||